The diagnosis and management of anaphylaxis practice parameter: 2010 Update (Q34130242)

31 July 2017

title

The diagnosis and management of anaphylaxis practice parameter: 2010 update (English)

1 reference

31 July 2017

The diagnosis and management of anaphylaxis practice parameter: 2010 Update (English)

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

18 June 2024

1 reference

1 reference

8

A Wesley Burks

1 reference

31 July 2017

20

Linda Cox

1 reference

31 July 2017

6

David I Bernstein

1 reference

31 July 2017

18

David I Bernstein

1 reference

31 July 2017

15

Dennis K Ledford

1 reference

31 July 2017

25

Jay M Portnoy

1 reference

31 July 2017

Phillip Lieberman

1

1 reference

31 July 2017

Richard A Nicklas

2

1 reference

31 July 2017

John Oppenheimer

3

1 reference

31 July 2017

Stephen F Kemp

4

1 reference

31 July 2017

Phillip Lieberman

16

1 reference

31 July 2017

Joann Blessing-Moore

19

1 reference

31 July 2017

David Lang

22

1 reference

31 July 2017

John Oppenheimer

24

1 reference

31 July 2017

Christopher Randolph

26

1 reference

31 July 2017

Stephen Tilles

29

1 reference

31 July 2017

Dana Wallace

30

1 reference

31 July 2017

Richard A. Nicklas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

Stephen F. Kemp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

David M. Lang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

Jonathan A. Bernstein

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

Anna M. Feldweg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

Jordan N. Fink

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

Paul A. Greenberger

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

David B. K. Golden

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

John M. James

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

Stephen F. Kemp

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

Albert L. Sheffer

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

David A. Khan

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

Richard A. Nicklas

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

Diane E. Schuller

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

Sheldon L. Spector

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

18 June 2024

language of work or name

English

0 references

publication date

7 August 2010

1 reference

full work available at URL

31 July 2017

http://www.jacionline.org/article/S0091674910010043/pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692689

https://api.elsevier.com/content/article/PII:S0091674910010043?httpAccept=text/xml

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

https://api.elsevier.com/content/article/PII:S0091674910010043?httpAccept=text/plain

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The Journal of Allergy and Clinical Immunology

18 June 2024

published in

1 reference

31 July 2017

volume

126

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

477-80.e1-42

1 reference

Epidemiology of anaphylaxis in Olmsted County: A population-based study

31 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Assessment of patients who have experienced anaphylaxis: a 3-year survey

18 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Biphasic anaphylactic reactions

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Exercise-induced anaphylaxis: epidemiologic observations

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Idiopathic anaphylaxis: a series of 335 cases

18 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Idiopathic anaphylaxis: a descriptive study of 81 patients in Spain

18 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985-1996).

18 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis in children: a 5-year experience

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis Manifested by Hypotension Alone

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Severe anaphylactic reactions outside hospital: etiology, symptoms and treatment

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Unexplained loss of consciousness: systemic mastocytosis.

18 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Utility of food-specific IgE concentrations in predicting symptomatic food allergy

18 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Paediatric emergency department anaphylaxis: different patterns from adults.

18 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients.

18 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation.

18 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Alcohol: intolerance syndromes, urticarial and anaphylactoid reactions

18 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Diagnostic value of tryptase in anaphylaxis and mastocytosis

18 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Can serum mast cell tryptase help diagnose anaphylaxis?

18 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study

18 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase

18 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Tryptase genetics and anaphylaxis

18 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Risk assessment in anaphylaxis: current and future approaches

18 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Increased mast cell tryptase in sudden infant death - anaphylaxis, hypoxia or artefact?

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Mast cell tryptase and hemolysis after trauma

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis

18 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology

18 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis

18 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The use of epinephrine in the treatment of anaphylaxis. AAAI Board of Directors

18 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The diagnosis and management of anaphylaxis: an updated practice parameter

18 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Systemic reactions and fatalities associated with allergen immunotherapy

18 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Biphasic and protracted anaphylaxis

18 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade.

18 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Epinephrine-resistant anaphylaxis in a patient taking propranolol hydrochloride

18 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication

18 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Fatal anaphylactic shock in a patient treated with beta-blockers

18 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Beta-adrenergic antagonists and fatal anaphylactic reactions to oral penicillin

18 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Severe anaphylactoid reaction to radiographic contrast media. Recurrences despites premedication with diphenhydramine and prednisone

18 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Severe adverse reactions to urography in patients taking beta-adrenergic blocking agents

18 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Glucagon reversal of hypotension in a case of anaphylactoid shock

18 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Risk of anaphylaxis in patients receiving beta-blocker drugs

18 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Systemic adverse effects of ophthalmic beta-blockers

18 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol

18 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations

18 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis

18 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Use of beta-blockers during immunotherapy for Hymenoptera venom allergy.

18 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Increased Risk for Anaphylactoid Reaction from Contrast Media in Patients on β-Adrenergic Blockers or with Asthma

18 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Utility of glucagon in the emergency department

18 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

A bronchodilator action of glucagon

18 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers

18 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The diagnosis and management of anaphylaxis

18 June 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Guidelines for the management of anaphylaxis in the emergency department

18 June 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Intraosseous drug administration in children and adults during cardiopulmonary resuscitation

18 June 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Does intraosseous equal intravenous? A pharmacokinetic study

18 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation

18 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial.

18 June 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation

18 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Successful treatment of severe anaphylactic shock with vasopressin. Two case reports

18 June 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Vasopressin for treatment of shock following aprotinin administration

18 June 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Intravenous cimetidine as an effective treatment for systemic anaphylaxis and acute allergic skin reactions

18 June 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Imipenem cross-reactivity with penicillin in humans

18 June 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Histamine antagonists in the treatment of acute allergic reactions

18 June 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Therapeutic controversies in the management of acute anaphylaxis

18 June 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Biphasic anaphylactic reactions

18 June 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis with associated fibrinolysis, reversed with tranexamic acid and demonstrated by thrombelastography.

18 June 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue

18 June 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis, killer allergy: long-term management in the community

18 June 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

SAFE: a multidisciplinary approach to anaphylaxis education in the emergency department

18 June 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

18 June 2024

9. Food allergy

94

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Sesame allergy in Britain: a questionnaire survey of members of the Anaphylaxis Campaign

18 June 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Sesame allergy: a growing food allergy of global proportions?

18 June 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

18 June 2024

Food anaphylaxis

97

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1- related PR-10 protein in soybean, SAM22.

18 June 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Latex allergy in subjects who had undergone multiple surgical procedures for bladder exstrophy: relationship with clinical intervention and atopic diseases

18 June 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Allergens and natural rubber proteins.

18 June 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Hair glue anaphylaxis: a hidden latex allergy

18 June 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Severe anaphylaxis induced by latex as a contaminant of plastic balls in play pits

18 June 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Latex allergy: frequent occurrence of IgE antibodies to a cluster of 11 latex proteins in patients with spina bifida and histories of anaphylaxis

18 June 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Clinical and laboratory-based methods in the diagnosis of natural rubber latex allergy

18 June 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs

18 June 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Systematic follow-up increases incidence of anaphylaxis during adverse reactions in anesthetized patients

18 June 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis to muscle relaxant drugs: cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay

18 June 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The Australian Incident Monitoring Study. Clinical anaphylaxis: an analysis of 2000 incident reports.

18 June 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The incidence and clinical features of anaphylactic reactions during anesthesia in Australia

18 June 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Adverse reactions to intravenous agents in anaesthesia in France

18 June 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicenter epidemiological inquiry

18 June 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000.

18 June 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis during surgical and interventional procedures

18 June 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Mechanisms in IgE-dependent anaphylaxis to anesthetic drugs

18 June 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Substituted ammonium ions as allergenic determinants in drug allergy

18 June 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Prick tests in the diagnosis of anaphylaxis to general anaesthetics

18 June 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects

18 June 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Allergy during anaesthesia

18 June 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis during induction of general anesthesia: subsequent evaluation and management

18 June 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Rocuronium: high risk for anaphylaxis?

18 June 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening

18 June 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

18 June 2024

Vancomycin Revisited

126

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy

18 June 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Hazards of Rapid Administration of Vancomycin

18 June 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions

18 June 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Antihistamine prophylaxis permits rapid vancomycin infusion

18 June 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis due to hydroxyethyl-starch-reactive antibodies

18 June 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Thiobarbiturate-induced histamine release in human skin mast cells.

18 June 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis due to thiopental sodium anesthesia

18 June 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylactic shock due to propofol

18 June 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis

18 June 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Hemodynamics, Plasma Histamine, and Catecholamine Concentrations during an Anaphylactoid Reaction to Morphine

18 June 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Hypersensitivity to intravenous morphine sulfate

18 June 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Histamine Release during Morphine and Fentanyl Anesthesia

18 June 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

High-titer protamine-specific IgG antibody associated with anaphylaxis: report of a case and quantitative analysis of antibody in vasectomized men

18 June 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin

18 June 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Neither skin tests nor serum enzyme-linked immunosorbent assay tests provide specificity for protamine allergy

18 June 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass

18 June 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylactoid reactions to protamine

18 June 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The diagnosis and management of anaphylaxis

18 June 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Allergy to protamine sulfate

18 June 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylactoid reaction to protamine confirmed by plasma tryptase in a diabetic patient during open heart surgery

18 June 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis to Muscle-Relaxant Drugs: Study of Cross-Reactivity by Skin Tests

18 June 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylactoid reaction to midazolam

18 June 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Midazolam-induced angioedema and bronchoconstriction

18 June 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Arginine vasopressin as a rescue vasopressor agent in the operating room

18 June 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Evaluation of mast cell activation (tryptase) in two patients suffering from drug-induced hypotensoid reactions

18 June 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Prevalence of human seminal plasma hypersensitivity among symptomatic women

18 June 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Prevalence of human seminal plasma hypersensitivity among symptomatic women

18 June 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Hypersensitivity reactions to human seminal plasma

18 June 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Allergy to human seminal plasma

18 June 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Allergy to human seminal fluid: characterization of the allergen and experience with immunotherapy

18 June 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Localized and systemic hypersensitivity reactions to human seminal fluid

18 June 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Postcoital urticaria in a penicillin-sensitive patient. Possible seminal transfer of penicillin

18 June 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Evaluation and treatment of localized vaginal immunoglobulin E-mediated hypersensitivity to human seminal plasma

18 June 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Combined allergy to human seminal plasma and latex: case report and review of the literature

18 June 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Immediate hypersensitivity to seminal fluid and atopic dermatitis

18 June 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Is burning semen syndrome a variant form of seminal plasma hypersensitivity?

18 June 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Selective desensitization to seminal plasma protein fractions after immunotherapy for postcoital anaphylaxis

18 June 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

18 June 2024

Allergy to coitus

177

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Seminal plasma anaphylaxis: successful pregnancy after intravaginal desensitization and immunodetection of allergens

18 June 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Intravaginal desensitization to seminal fluid

18 June 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Intravaginal desensitization and successful pregnancy in a woman with seminal fluid allergy

18 June 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Local intravaginal desensitization to seminal fluid

18 June 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The approach to conception for women with seminal plasma protein hypersensitivity

18 June 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Exercise-induced anaphylactic reaction to shellfish

18 June 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Exercise-induced anaphylaxis

18 June 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study

18 June 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Food-dependent, exercise-induced anaphylaxis: a study on 11 Japanese cases

18 June 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis

18 June 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Food-dependent exercise-induced anaphylaxis

18 June 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Frequency of food-dependent, exercise-induced anaphylaxis in Japanese junior-high-school students

18 June 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Exercise-induced anaphylaxis: a distinct form of physical allergy

18 June 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Exercise-induced anaphylaxis: a serious form of physical allergy associated with mast cell degranulation

18 June 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

18 June 2024

Idiopathic anaphylaxis

194

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Exercise-induced urticaria, angioedema, and anaphylactoid episodes

18 June 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Elevated serum tryptase in exercise-induced anaphylaxis

18 June 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Food-Dependent Exercise-Induced Anaphylaxis: Clinical and Laboratory Findings in 54 Subjects

18 June 2024

197

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Exercise-induced anaphylaxis

18 June 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice

18 June 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Antiulcer drugs promote oral sensitization and hypersensitivity to hazelnut allergens in BALB/c mice and humans

18 June 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients

18 June 2024

203

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Measurement of urinary histamine: development of methodology and normal values

18 June 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Prolonged elevation of serum tryptase in idiopathic anaphylaxis

18 June 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Serum tryptase in idiopathic anaphylaxis: a case report and review of the literature

18 June 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders

18 June 2024

208

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Lymphocyte subsets and activation markers in patients with acute episodes of idiopathic anaphylaxis

18 June 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Outcome of prophylactic therapy for idiopathic anaphylaxis

18 June 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

18 June 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis

18 June 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Undifferentiated somatoform idiopathic anaphylaxis: nonorganic symptoms mimicking idiopathic anaphylaxis

18 June 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Fatalities from immunotherapy (IT) and skin testing (ST)

18 June 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Survey of fatalities from skin testing and immunotherapy 1985-1989.

18 June 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Systemic reactions and fatalities associated with allergen immunotherapy

18 June 2024

216

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

18 June 2024

217

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy

18 June 2024

218

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Clinical experience with penicillin skin testing in a large inner-city STD clinic

18 June 2024

219

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Evaluation of near-fatal reactions to allergen immunotherapy injections

18 June 2024

220

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Allergen immunotherapy: a practice parameter second update

18 June 2024

222

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylactic reactions during immunotherapy

18 June 2024

223

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections

18 June 2024

224

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Relapsing anaphylaxis to bee sting in a patient treated with beta-blocker and Ca blocker.

18 June 2024

225

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy

18 June 2024

227

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party

18 June 2024

228

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults

18 June 2024

229

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prospective study of the penicillin study group of the American Academy of Allergy

18 June 2024

230

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization

18 June 2024

231

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Determination of the incidence of sensitization after penicillin skin testing

18 June 2024

232

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Cephalosporins can be given to penicillin-allergic patients who do not exhibit an anaphylactic response

18 June 2024

233

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Hypersensitivity Reactions to Beta-Lactam Antibiotics

18 June 2024

234

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Safety of cephalosporin administration to patients with histories of penicillin allergy

18 June 2024

235

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Under-reporting of antibiotic anaphylaxis may put patients at risk

18 June 2024

236

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Anaphylaxis to Cephalothin in a Patient Allergic to Penicillin

18 June 2024

237

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Lack of cross-reactivity between aztreonam , a monobactam antibiotic, and penicillin in penicillin-allergic subjects

18 June 2024

240

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Imipenem in Patients with Immediate Hypersensitivity to Penicillins

18 June 2024

241

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Tolerability of imipenem in children with IgE-mediated hypersensitivity to penicillins

18 June 2024

242

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics

18 June 2024

243

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Aspirin and NSAID sensitivity

18 June 2024

244

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Emergency department anaphylaxis: A review of 142 patients in a single year

18 June 2024

245

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Carboplatin desensitization

18 June 2024

246

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity

18 June 2024

247

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Severe hypotension complicating primary angioplasty: allergy to abciximab

18 June 2024

248

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents

18 June 2024

249

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases

18 June 2024

250

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Contaminated heparin associated with adverse clinical events and activation of the contact system

18 June 2024

252

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Cetuximab-associated infusion reactions: pathology and management

18 June 2024

253

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma

18 June 2024

254

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis

18 June 2024

255

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose

18 June 2024

256

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

A desensitization protocol for the mAb cetuximab.

18 June 2024

257

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose

18 June 2024

258

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Treatment of systemic reactions to contrast media

18 June 2024

259

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Adverse reactions to contrast media: a report from the Committee on Safety of Contrast Media of the International Society of Radiology.

18 June 2024

260

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media

18 June 2024

261

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Ionic versus nonionic contrast agents for intravenous use: are all the answers in?

18 June 2024

262

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment

18 June 2024

264

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The role of a documented allergic profile as a risk factor for radiographic contrast media reaction

18 June 2024

265

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Emergency administration of radiocontrast media in high-risk patients

18 June 2024

267

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Severe anaphylactoid reaction to radiographic contrast media. Recurrences despites premedication with diphenhydramine and prednisone

18 June 2024

268

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Timing of venom skin tests and IgE determinations after insect sting anaphylaxis

18 June 2024

269

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Diagnostic methods for insect sting allergy

18 June 2024

270

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Responsibility for quality IgE antibody results rests ultimately with the referring physician

18 June 2024

271

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

A controlled trial of immunotherapy in insect hypersensitivity

18 June 2024

272

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract

18 June 2024

273

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols.

18 June 2024

275

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Safety and efficacy of an imported fire ant rush immunotherapy protocol with and without prophylactic treatment

18 June 2024

276

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Imported fire ant immunotherapy: effectiveness of whole body extracts

18 June 2024

277

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Use of beta-blockers during immunotherapy for Hymenoptera venom allergy.

18 June 2024

278

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Wasp sting‐associated cold urticaria

18 June 2024

279

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy.

18 June 2024

280

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Unusual reactions following insect stings. Clinical features and immunologic analysis

18 June 2024

281

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Late-onset allergic reactions, including serum sickness, after insect stings.

18 June 2024

282

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Studies of 400 Hymenoptera sting deaths in the United States

18 June 2024

283

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The Hymenoptera venom study I, 1979-1982: demographics and history-sting data

18 June 2024

284

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

An epidemiologic study of insect allergy in children. I. Characteristics of the disease.

18 June 2024

285

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Ant allergy in Asia and Australia.

18 June 2024

287

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Insect sting allergy and venom immunotherapy: a model and a mystery

18 June 2024

290

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Epidemiology of Insect Venom Sensitivity

18 June 2024

291

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Natural history of Hymenoptera venom sensitivity in adults

18 June 2024

292

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Clinical and entomological factors influence the outcome of sting challenge studies

18 June 2024

293

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Treatment Failures With Whole-Body Extract Therapy of Insect Sting Allergy

18 June 2024

295

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Clinical and immunologic studies of patients with large local reactions following insect stings

18 June 2024

296

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Stinging insect hypersensitivity: a practice parameter update

18 June 2024

297

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Immunoglobulin E antibodies that crossreact with vegetable foods, pollen, and Hymenoptera venom

18 June 2024

298

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Reproducibility of skin testing and serum venom specific IgE in Hymenoptera venom allergy.

18 June 2024

299

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Intentional diagnostic insect sting challenges: a medical and ethical issue.

18 June 2024

300

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The sting challenge test in Hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology

18 June 2024

301

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity.

18 June 2024

302

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions

18 June 2024

303

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Outcomes of allergy to insect stings in children, with and without venom immunotherapy

18 June 2024

304

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

A prospective study of the natural history of large local reactions after Hymenoptera stings in children.

18 June 2024

305

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Natural history of large local reactions from stinging insects.

18 June 2024

306

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

The value of immunotherapy with venom in children with allergy to insect stings

18 June 2024

307

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial

18 June 2024

308

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensiti

18 June 2024

309

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Safety of Angiotensin-converting enzyme inhibitors in patients with insect venom allergies.

18 June 2024

310

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

Multicenter study of emergency department visits for insect sting allergies

18 June 2024

311

1 reference

https://api.crossref.org/works/10.1016/J.JACI.2010.06.022

18 June 2024

Identifiers

1 reference

31 July 2017

1 reference